Evidence map›Paper›PMID 35460513›Full record

ReviewSports medicine (Auckland, N.Z.)2022

Does a Hypertrophying Muscle Fibre Reprogramme its Metabolism Similar to a Cancer Cell?

Henning Wackerhage, Ivan J Vechetti, Philipp Baumert, Sebastian Gehlert, Lore Becker, Richard T Jaspers, Martin Hrabě de Angelis

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Sports medicine (Auckland, N.Z.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07721766 (HyperLa), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07721766 narecruitingnot on this mapstarted 2026, after this paper: background citation

HyperLa: Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training: A Multi-centre Study by the HyperLa Study Group

TypeinterventionalSponsorTechnical University of MunichRan2026 to 2026Enrolled120ConditionsHealthy Volunteers, Muscle Hypertrophy, Glycolysis, Moderately TrainendArmsHypertrophy-focused Resistance Training
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Skeletal muscle hypertrophy: cell growth is cell growth.American journal of physiology. Cell physiology · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Henning WackerhageExercise Biology Group, Department of Health and Sports Sciences, Technical University of Munich, Munich, Germany. henning.wackerhage@tum.de.ORCID http://orcid.org/0000-0001-5920-5842
Ivan J VechettiDepartment of Nutrition and Health Sciences, College of Education and Human Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA.
Philipp BaumertExercise Biology Group, Department of Health and Sports Sciences, Technical University of Munich, Munich, Germany.
Sebastian GehlertDepartment of Biosciences of Sports, Institute for Sports Science, University of Hildesheim, Hildesheim, Germany.
Lore BeckerInstitute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.
Richard T JaspersLaboratory for Myology, Behavioural and Movement Sciences, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Martin Hrabě de AngelisInstitute of Experimental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany.
Helmholtz Zentrum München · DETechnical University of Munich · DEUniversity of Hildesheim · DEUniversity of Nebraska–Lincoln · USVrije Universiteit Amsterdam · NL

Funding

European Research Council 754462
6 · The paper itself

Abstract

In 1924, Otto Warburg asked "How does the metabolism of a growing tissue differ from that of a non-growing tissue?" Currently, we know that proliferating healthy and cancer cells reprogramme their metabolism. This typically includes increased glucose uptake, glycolytic flux and lactate synthesis. A key function of this reprogramming is to channel glycolytic intermediates and other metabolites into anabolic reactions such as nucleotide-RNA/DNA synthesis, amino acid-protein synthesis and the synthesis of, for example, acetyl and methyl groups for epigenetic modification. In this review, we discuss evidence that a hypertrophying muscle similarly takes up more glucose and reprogrammes its metabolism to channel energy metabolites into anabolic pathways. We specifically discuss the functions of the cancer-associated enzymes phosphoglycerate dehydrogenase and pyruvate kinase muscle 2 in skeletal muscle. In addition, we ask whether increased glucose uptake by a hypertrophying muscle explains why muscularity is often negatively associated with type 2 diabetes mellitus and obesity.

Indexed as

Diabetes Mellitus, Type 2NeoplasmsAmino AcidsDNAGlucoseHumansLactatesMuscle Fibers, SkeletalNucleotidesPhosphoglycerate DehydrogenasePyruvate KinaseRNAAmino AcidsDNAGlucoseLactatesNucleotidesPhosphoglycerate DehydrogenasePyruvate KinaseRNA

Identifiers

PMID35460513
PMCPMC9584876
OpenAlexW4224326463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.